[1]Anderson B.The use of remifentanil as the primary agent for analgesia in parturients[J].Crit Care Nurs Clin North Am,2017,29:495-517. [2]Kim SH,Stoicea N,Soghomonyan S,et al.Remifentanil-acute opioid tolerance and opioid-induced hyperalgesia:a systematic review[J].Am J Ther,2015,22:e62-74. [3]周据津.纳布啡与舒芬太尼用于剖宫产术后镇痛临床效果的比较[D].河南:郑州大学,2017. [4]张瑜,何万友,梁顺萍,等.纳布啡预防瑞芬太尼诱发术后痛觉敏化的效果评价[J].中国新药杂志,2016,25:2688-2691. [5]Brennan TJ,Vandermeulen EP,Gebhart GF.Characteriza-tion of a rat model of incisional pain[J].Pain,1996,64:493-501. [6]Kim SH, Stoicea N, Soghomonyan S, et al.Remifentanil-acute opioid tolerance and opioid-induced hyperalgesia:a systematic review[J].Am J Ther,2015,22:e62-74. [7]王敦亮,王秘群,申荣,等.盐酸纳布啡注射液用于剖宫产术后镇痛的临床研究及其对产后抑郁的预防作用[J].中国临床药理学杂志,2017,33:782-785. [8]Narver HL.Nalbuphine,a non-controlled opioid analgesic,and its potential use in research mice[J].Lab Anim (NY),2015,44:106-110. [9]Jannuzzi RG.Nalbuphine for treatment of opioid-induced pruritus:A systematic review of literature[J].Clin J Pain,2016,32:87-93. [10]Li XH,Miao HH,Zhuo M.NMDA receptor dependent long-term potentiation in chronic pain[J].Neurochem Res,2019,44:531-538. [11]Borges G,Berrocoso E,Mico JA,et al. ERK1/2: function, signaling and implication in pain and pain-related anxio-depressive disorders[J].Prog Neuropsychopharmacol Biol Psychiatry,2015,60:77-92. [12]Roeckel LA,Le Coz GM,Gavériaux-Ruff C,et al.Opioid-induced hyperalgesia: cellular and molecular mechanisms[J].Neuroscience,2016,338:160-182. [13]Van den Heuvel I,Reichl S,Segelcke D,et al.Selective prevention of mechanical hyperalgesia after incision by spinal ERK1/2 inhibition[J].Eur J Pain,2015,19:225-235. |